Swiss stocks – Factors to watch on May 19

ZURICH, May 19 – Swiss stocks were set to ease on Wednesday,
in line with other bourses, as Germany’s decision to ban naked
short-selling of some bonds, stocks and credit protection was
hitting investors’ sentiment globally.

The Swiss blue-chip index SMI(.SSMI: ) was indicated to fall
55 points to 6,414 points, premarket data provided by bank
Clariden Leu showed.(CLPRE: )

The following are some of the main factors expected to
affect Swiss stocks on Wednesday.

ROCHE (ROG.VX: )

Roche and Biogen Idec end the ocrelizumab clinical
development programme in patients with rheumatoid arthritis.

For related news, click on [ROG.VX]

NOVARTIS (NOVN.VX: )

Current and former female employees of drugmaker Novartis
want up to $285 million in punitive damages after winning a
ruling that a U.S. division of the company engaged in a pattern
of discrimination, a lawyer for the women said on Tuesday.

For related news, click on [NOVN.VX]

ECONOMY [M-CH]

Switzerland’s currency reserves soared in April, data
published on the country’s statistics office website showed on
Wednesday, reflecting massive currency interventions by the
Swiss National Bank.

For related news, click on [ID:nWEA2915]

COMPANY STATEMENTS [CNR-CH]

* Phoenix Mecano (PM.S: ) is to acquire full ownership of
Germany’s Lohse GmbH with retroactive effect from 1 May 2010,
expanding its solar business [PM.S]

* Addex Pharmaceuticals(ADXN.S: ) announced the departure of
Emmanuel le Poul, Head of the CNS Business Unit [ADXN.S]

EQUITY RESEARCH [CH-RCH]

FOR COMPANIES TRADING EX-DIVIDEND, PLEASE CLICK ON:

(.EX.S: ) for all Swiss stocks

(.EXSMI.S: ) for blue chips

(.EXNSMI.S: ) for other stocks

Money

Swiss stocks – Factors to watch on May 19